These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7916118)

  • 1. Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats.
    Carter WJ; Lynch ME
    Metabolism; 1994 Sep; 43(9):1119-25. PubMed ID: 7916118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clenbuterol on skeletal muscle mass, body composition, and recovery from surgical stress in senescent rats.
    Carter WJ; Dang AQ; Faas FH; Lynch ME
    Metabolism; 1991 Aug; 40(8):855-60. PubMed ID: 1861634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of clenbuterol on recovery of muscle mass and carcass protein content following dietary protein depletion in young and old rats.
    Carter WJ; Lynch ME
    J Gerontol; 1994 Jul; 49(4):B162-8. PubMed ID: 8014387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of clenbuterol on recovery of muscle mass and carcass protein content following experimental hyperthyroidism in old rats.
    Carter WJ; Lynch ME
    Comp Biochem Physiol Comp Physiol; 1994; 108(2-3):387-94. PubMed ID: 7914859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anabolic effects of the beta 2-adrenoceptor agonist salmeterol are dependent on route of administration.
    Moore NG; Pegg GG; Sillence MN
    Am J Physiol; 1994 Sep; 267(3 Pt 1):E475-84. PubMed ID: 7943228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation.
    Choo JJ; Horan MA; Little RA; Rothwell NJ
    Am J Physiol; 1992 Jul; 263(1 Pt 1):E50-6. PubMed ID: 1322047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of a beta-agonist and a beta-agonist/beta-antagonist combination on muscle growth, body composition and protein metabolism in rats].
    Reichel K; Rehfeldt C; Weikard R; Schadereit R; Krawielitzki K
    Arch Tierernahr; 1993; 45(3):211-25. PubMed ID: 8585791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats.
    Chen KD; Alway SE
    J Appl Physiol (1985); 2000 Aug; 89(2):606-12. PubMed ID: 10926644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats.
    Bonnet N; Benhamou CL; Brunet-Imbault B; Arlettaz A; Horcajada MN; Richard O; Vico L; Collomp K; Courteix D
    Bone; 2005 Nov; 37(5):622-33. PubMed ID: 16157516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clenbuterol reduces soleus muscle fatigue during disuse in aged rats.
    Chen KD; Alway SE
    Muscle Nerve; 2001 Feb; 24(2):211-22. PubMed ID: 11180204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the beta 2-adrenergic agonist clenbuterol on capillary geometry in cardiac and skeletal muscles in young and middle-aged rats.
    Suzuki J; Gao M; Xie Z; Koyama T
    Acta Physiol Scand; 1997 Nov; 161(3):317-26. PubMed ID: 9401584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of trabecular bone under chronic beta2 agonists treatment.
    Bonnet N; Brunet-Imbault B; Arlettaz A; Horcajada MN; Collomp K; Benhamou CL; Courteix D
    Med Sci Sports Exerc; 2005 Sep; 37(9):1493-501. PubMed ID: 16177600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth.
    Carbó N; López-Soriano J; Tarragó T; González O; Llovera M; López-Soriano FJ; Argilés JM
    Cancer Lett; 1997 May; 115(1):113-8. PubMed ID: 9097986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clenbuterol and salbutamol on tissue rubidium uptake in vivo.
    Cartañà J; Stock MJ
    Metabolism; 1995 Jan; 44(1):119-25. PubMed ID: 7854156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of contractile force and mass in the senescent diaphragm with beta(2)-agonist treatment.
    Smith WN; Dirks A; Sugiura T; Muller S; Scarpace P; Powers SK
    J Appl Physiol (1985); 2002 Mar; 92(3):941-8. PubMed ID: 11842024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a beta-agonist (clenbuterol) on growth, carcass composition, protein and energy metabolism of veal calves.
    Williams PE; Pagliani L; Innes GM; Pennie K; Harris CI; Garthwaite P
    Br J Nutr; 1987 May; 57(3):417-28. PubMed ID: 3593670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anabolic effects of clenbuterol after long-term treatment and withdrawal in t the rat.
    Cartañà J; Segués T; Yebras M; Rothwell NJ; Stock MJ
    Metabolism; 1994 Sep; 43(9):1086-92. PubMed ID: 8084283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clenbuterol and ICI118551, a selective beta 2-antagonist, on the growth of skeletal muscle of suckling rats.
    Morton RH; Agbenyega ET; Hatton PA; Wareham AC
    Pflugers Arch; 1995 Dec; 431(2):237-43. PubMed ID: 9026784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased myofibrillar protein breakdown following treatment with clenbuterol.
    Benson DW; Foley-Nelson T; Chance WT; Zhang FS; James JH; Fischer JE
    J Surg Res; 1991 Jan; 50(1):1-5. PubMed ID: 1670961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clenbuterol attenuates muscle atrophy and dysfunction in hindlimb-suspended rats.
    Dodd SL; Koesterer TJ
    Aviat Space Environ Med; 2002 Jul; 73(7):635-9. PubMed ID: 12137098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.